重药控股:荣获Wind ESG评级A级 可持续发展实力获权威认证

Group 1 - The core viewpoint of the article highlights that Zhongyao Holdings has made significant progress in sustainable development, achieving an upgrade in ESG rating from BB to A, moving from 71st to 8th among 114 healthcare providers and service companies [2] - In 2023, Zhongyao Holdings accelerated its collaborative development with the General Technology Group, enhancing its marketing and supply chain capabilities, and expanding its product matrix across 21 provinces with 102 new accounts, including 86 grade hospitals [2] - The company reported a revenue of 20.612 billion yuan in Q1, a year-on-year increase of 5.03%, and a net profit attributable to shareholders of 125 million yuan, up 21.63% year-on-year, with a basic earnings per share of 0.07 yuan [2] Group 2 - Looking ahead, Zhongyao Holdings emphasizes the integration of sustainable development into its corporate strategy, focusing on compliance, green low-carbon initiatives, and social contributions, aiming to create a win-win industrial ecosystem [3] - The company is committed to balancing economic and social benefits while enhancing its ESG governance model, with a mission to lead a better life through technological advancement and quality service [3]